FDA Import Refusal 8NP-0089026-3/11/1 — MSD Ireland (Carlow)
The FDA refused shipment 8NP-0089026-3/11/1 from MSD Ireland (Carlow) (Ireland) on October 10, 2023. The refused product falls under Drugs and Biologics — PEMBROLIZUMAB (ANTI-NEOPLASTIC - PART II). Cited charge: 75
Refusal Details
- Date
- October 10, 2023
- Country
- Ireland
- Product Category
- Drugs and Biologics
- Product Code
- 62ZBY31 PEMBROLIZUMAB (ANTI-NEOPLASTIC - PART II)
- Charges
- 75